Stefan Werner

Stefan Werner is a Privatdozent and Head of Research Group at the Institute of Tumor Biology, part of the Faculty of Medicine at the University of Hamburg. His work focuses on tumor biology, particularly in prostate and breast cancers, with emphasis on circulating tumor cells (CTCs), liquid biopsy applications, and therapeutic targeting strategies. He leads a research group investigating mechanisms of metastasis, tumor dormancy, and resistance to treatment. Key contributions include studies on TROP2 targeting in prostate cancer, HERC5 regulation in lung cancer, and the role of RAI2 in epigenetic suppression.

Research interests span oncology, molecular medicine, and translational cancer research. His team employs advanced techniques like nanopore sequencing and molecular imaging to advance precision medicine. Collaborations include work with the Mildred Scheel Cancer Center and the European Liquid Biopsy Society. He is affiliated with the University Cancer Center Hamburg (UCCH) and has published extensively in journals such as Nature Communications, Journal of Clinical Oncology, and Cancer Research.

Werner’s research bridges basic science and clinical applications, addressing critical gaps in understanding metastasis and developing novel diagnostic tools. His work highlights the importance of CTC analysis for monitoring tumor recurrence and dormancy states, contributing to personalized cancer care strategies.